GLENMARK

1,966.5 INR
19.1
0.96%
Last update Dec 16, 3:29 PM IST
Market closed
Day range
1,957.90002
1,992.40002
Previous close
1,985.59998
Open
1,988.80005
Access this stock data via API
Subscribe
Glenmark Pharmaceuticals Ltd.
1,966.50
19.10
0.96%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 60.0B 30.6B 32.2B 33.0B
Cost of revenue 12.6B 10.2B 14.9B 10.8B
Gross profit 47.4B 20.4B 17.3B 22.2B
Operating expense
Research & development
Selling general and admin
Other operating expenses 13.4B 9.1B -13.2B 9.1B
Operating income 22.2B 4.5B 4.4B 4.8B
Non operating interest income
Income
Expense 664.6M 582.3M 667.1M 522.9M
Other income expense
Pretax income 9.7B 955.8M 79.7M 4.6B
Tax provision 3.6B 486.1M 35.9M 1.1B
Net income 6.1B 469.7M 43.8M 3.5B
Basic EPS 21.6 1.7 12.3
Diluted EPS 21.6 1.7 12.3
Basic average shares 282.2M 282.4M 282.2M
Diluted average shares 282.3M 282.4M 282.2M
EBITDA 25.6B 6.1B 2.0B 6.3B
Net income from continuing op.
Minority interests -790K -1.0M 2.7M -690K
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 4 hours 9 minutes

05:05
00:00
09:15
15:30
23:59

Trading Hours (Sunday - Thursday):

Main market
09:15 - 15:30
All times are displayed in the Asia/Kolkata timezone (IST, UTC+05:30).